首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1477275

癌症治療市場，依治療類型，依癌症類型，依地理位置

Cancer Therapy Market, By Therapy Type, By Cancer Type, By Geography

出版日期: 2024年04月12日 | 出版商:

Coherent Market Insights | 英文 174 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年癌症治療市場價值為2,051億美元，預計到2031年將達到4,662.1億美元，2024年至2031年的年複合成長率（CAGR）為12.4%。

報告範圍		報告詳情
基準年：	2023年	2024 年市場規模：	2051億美元
歷史數據：	2019年至2023年	預測期：	2024年至2031年
預測 2024 年至 2031 年複合年成長率：	12.40%	2031 年價值預測：	4662.1 億美元

圖 1. 2024 年癌症治療市佔率 (%)（依地區）

癌症持續為全世界的醫療保健帶來重大課題。許多國家的人口迅速老化導致癌症盛行率上升。此外，環境污染水平的增加和生活方式的改變，如不健康的飲食、缺乏體力活動、吸煙和飲酒，增加了人群患癌症的風險。儘管治療干預措施取得了進步，但癌症死亡率仍然很高。因此，腫瘤學領域的藥物開發活動近年來有所加強，重點是改善患者的治療結果和生活品質。

市場動態：

癌症治療市場受到多種因素的推動，例如生活方式的改變導致全球癌症盛行率不斷上升、老年人口不斷成長、標靶治療和個人化醫療的日益採用、新興國家醫療保健基礎設施的擴張以及癌症研發投資的增加由製藥公司。然而，與癌症護理相關的高治療成本限制了廣泛採用。此外，新藥核准週期長也在一定程度上對市場成長構成課題。同時，強大的癌症臨床試驗管道和生物相似藥的進入為預測期內的市場擴張提供了重大機會。

研究的主要特點：

該報告對全球癌症治療市場進行了深入分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它闡明了不同區隔市場的潛在收入成長機會，並解釋了該市場有吸引力的投資主張矩陣。
這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
它根據以下參數描述了全球癌症治療市場的主要參與者——公司亮點、產品組合、主要亮點、財務表現和策略。
該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球癌症治療市場報告迎合了該行業的各個利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
利害關係人可以透過用於分析全球癌症治療市場的各種策略矩陣輕鬆做出決策。

介紹
北美洲
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地區
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
東協
澳洲
韓國
亞太地區其他地區
中東
海灣合作理事會
以色列
中東其他地區
非洲
北非
中非
南非

第 8 章：競爭格局

公司簡介
- Bristol-Myers Squibb Company
- AstraZeneca
- Pfizer Inc.
- Novartis AG
- GSK plc.
- Sanofi
- Bayer AG
- Amgen Inc.
- Gilead Sciences, Inc.
- Boehringer Ingelheim International GmbH.
- ADC Therapeutics SA
- F. Hoffmann-La Roche Ltd
- Merck & Co., Inc.
- Eureka Therapeutics, Inc.
- AbbVie Inc.
- Fate Therapeutics
- Sorrento Therapeutics, Inc.
- Carrick Therapeutics Limited
- Atara Biotherapeutics, Inc.
- Celluris
- NeoTX
- Kazia Therapeutics Limited

第 9 章：分析師觀點

命運之輪
分析師觀點
連貫的機會圖

第 10 章：參考文獻與研究方法

參考
研究方法論

簡介目錄

Product Code: CMI5335

The cancer therapy market is estimated to be valued at USD 205.10 Bn in 2024 and is expected to reach USD 466.21 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 12.4% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 205.10 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	12.40%	2031 Value Projection:	US$ 466.21 Bn

Figure 1.Cancer Therapy Market Share (%), By Region, 2024

Cancer continues to pose significant healthcare challenges worldwide. Rapidly aging population profiles in numerous countries have contributed to the rising cancer prevalence. Furthermore, increasing environmental pollution levels and lifestyle changes such as unhealthy diets, lack of physical activity, tobacco use, and alcohol consumption have elevated the cancer risk in populations. Despite advancements in therapeutic interventions, cancer mortality remains substantial. As a result, drug development activity in the oncology sector has intensified in recent times focused on improving patient outcomes and quality of life.

Market Dynamics:

The cancer therapy market is driven by various factors such as the increasing prevalence of cancer worldwide owing to changing lifestyle patterns, growing geriatric population, increasing adoption of targeted therapies and personalized medicine, expansion of healthcare infrastructure across emerging nations, and rising investment in cancer R&D by pharmaceutical companies. However, high treatment costs associated with cancer care pose limitations to widespread adoption. Moreover, long regulatory approval timelines for new drug approvals also challenge market growth to some extent. Meanwhile, robust cancer clinical trial pipelines and the entry of biosimilars provide significant opportunities for market expansion over the forecast period.

Key Features of the Study:

This report provides an in-depth analysis of the global cancer therapy market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global cancer therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study includes Bristol-Myers Squibb Company, AstraZeneca, Pfizer Inc., Novartis AG, GSK plc., Sanofi, Bayer AG, Amgen Inc., Gilead Sciences, Inc., Boehringer Ingelheim International GmbH., ADC Therapeutics SA, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Eureka Therapeutics, Inc., AbbVie Inc., Fate Therapeutics, Sorrento Therapeutics, Inc., Carrick Therapeutics Limited, Atara Biotherapeutics, Inc., Celluris, NeoTX, and Kazia Therapeutics Limited.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global cancer therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer therapy market.

Detailed Segmentation-

Therapy Type:
- Chemotherapy
- Alkylating agents
- Antimetabolites
- Anti-tumor antibiotics
- Others
- Target Therapy
- Monoclonal antibodies
- Small molecule inhibitors
- Others
- Immunotherapy
- Immune Checkpoint Inhibitors
- Oncolytic virus therapy
- T-cell therapy
- Radiotherapy
- Others
Cancer Type:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Blood Cancer
- Liver Cancer
- Thyroid Cancer
- Head and Neck Cancer
- Skin Cancer
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- AstraZeneca
- Pfizer Inc.
- Novartis AG
- GSK plc.
- Sanofi
- Bayer AG
- Amgen Inc.
- Gilead Sciences, Inc.
- Boehringer Ingelheim International GmbH.
- ADC Therapeutics SA
- Hoffmann-La Roche Ltd
- Merck & Co., Inc.
- Eureka Therapeutics, Inc.
- AbbVie Inc.
- Fate Therapeutics
- Sorrento Therapeutics, Inc.
- Carrick Therapeutics Limited
- Atara Biotherapeutics, Inc.
- Celluris
- NeoTX
- Kazia Therapeutics Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Therapy Type
- Market Snapshot, By Cancer Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Acquisitions and Partnerships Scenario
Reimbursement Scenario
Epidemiology
Treatment Algorithm (Patient Journey)
Cancer Diagnosis and Treatment Options
Pipeline Analysis
Patient Advocacy and Empowerment
Regulatory Scenario
Pricing Analysis
PEST Analysis
PORTER's Analysis

4. Global Cancer Therapy Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 impact on the market

5. Global Cancer Therapy Market, By Therapy Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Chemotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Alkylating agents
Antimetabolites
Anti-tumor antibiotics
Others
Target Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Monoclonal antibodies
Small molecule inhibitors
Others
Immunotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Immune Checkpoint Inhibitors
Oncolytic virus therapy
T-cell therapy
Radiotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Cancer Therapy Market, By Cancer Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Breast Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Lung Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Colorectal Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Prostate Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Blood Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Liver Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Thyroid Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Head and Neck Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Skin Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Cancer Therapy Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
North Africa
Central Africa
South Africa

8. Competitive Landscape

Company Profiles
- Bristol-Myers Squibb Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- AstraZeneca
- Pfizer Inc.
- Novartis AG
- GSK plc.
- Sanofi
- Bayer AG
- Amgen Inc.
- Gilead Sciences, Inc.
- Boehringer Ingelheim International GmbH.
- ADC Therapeutics SA
- F. Hoffmann-La Roche Ltd
- Merck & Co., Inc.
- Eureka Therapeutics, Inc.
- AbbVie Inc.
- Fate Therapeutics
- Sorrento Therapeutics, Inc.
- Carrick Therapeutics Limited
- Atara Biotherapeutics, Inc.
- Celluris
- NeoTX
- Kazia Therapeutics Limited